MAML3 Activators
MAML3 activators belong to a chemical class of compounds that play a crucial role in regulating the activity of the Mastermind-Like 3 (MAML3) protein. MAML3 is a transcriptional co-activator that is involved in various cellular processes, particularly in the context of gene expression and transcriptional regulation. It is a member of the Mastermind-like (MAML) family of proteins, which interact with Notch receptors and function as co-factors in the Notch signaling pathway. This pathway is highly conserved and plays a pivotal role in cell fate determination, development, and tissue homeostasis in various organisms, including humans.
Activators of MAML3 are molecules that have the capacity to modulate the function or expression of this specific co-activator. These activators can potentially influence the Notch signaling pathway, as MAML3 is an essential component of this pathway. Through its interaction with Notch receptors and other co-activators, MAML3 contributes to the transcription of downstream target genes involved in diverse cellular processes, including differentiation, proliferation, and survival. The regulation of MAML3 activity by activators is significant for understanding the molecular mechanisms underlying the Notch signaling pathway and its implications in various biological contexts, ranging from embryonic development to cancer biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate gene expression and may affect the NOTCH signaling pathway, potentially upregulating MAML3. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
By inhibiting NOTCH processing, gamma-secretase inhibitors could alter MAML3 expression as part of feedback regulation in the pathway. | ||||||
Wnt Agonist | 853220-52-7 | sc-222416 sc-222416A | 5 mg 25 mg | $157.00 $609.00 | 23 | |
Wnt signaling can interact with NOTCH signaling, potentially affecting the expression of MAML3. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can activate Wnt/beta-catenin signaling, which might cross-talk with NOTCH signaling and modulate MAML3 expression. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
As a Hedgehog signaling inhibitor, cyclopamine might indirectly affect MAML3 expression through pathway crosstalk. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
HDAC inhibitors can change chromatin structure and affect the expression of various genes, including MAML3. | ||||||
Proteasome Inhibitor I | 158442-41-2 | sc-3127 | 1 mg | $87.00 | 1 | |
By preventing protein degradation, proteasome inhibitors could increase the levels of transcription factors that regulate MAML3 expression. | ||||||
Glucocorticoid Receptor Modulator, CpdA | 14593-25-0 | sc-221677 | 25 mg | $150.00 | 2 | |
Glucocorticoids can influence numerous signaling pathways and may have an impact on MAML3 expression. | ||||||
JAK Inhibitor I | 457081-03-7 | sc-204021 sc-204021A | 500 µg 1 mg | $156.00 $339.00 | 59 | |
Inhibitors of the JAK/STAT pathway could modify the transcriptional landscape, potentially affecting MAML3 levels. | ||||||